SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 39 filers reported holding SAB BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $9,453 | +9.1% | 13,750 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $8,663 | -24.1% | 13,750 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $11,413 | +88.6% | 13,750 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $6,050 | -25.4% | 13,750 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $8,111 | -90.6% | 13,750 | +25.0% | 0.00% | -92.3% |
Q4 2021 | $86,000 | – | 11,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First PREMIER Bank | 807,535 | $509 | 0.16% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 192,027 | $120,977 | 0.02% |
Strategic Financial Concepts, LLC | 15,027 | $9,467 | 0.00% |
LGL PARTNERS, LLC | 23,000 | $14,490 | 0.00% |
Elgethun Capital Management | 9,935 | $6,358 | 0.00% |
PATHSTONE FAMILY OFFICE, LLC | 506,513 | $319,103 | 0.00% |
Nadler Financial Group, Inc. | 13,750 | $8,663 | 0.00% |
FIRST MANHATTAN CO. LLC. | 277,777 | $174,999 | 0.00% |
Gs Investments, Inc. | 2,000 | $1,260 | 0.00% |
PEAPACK GLADSTONE FINANCIAL CORP | 52,296 | $33 | 0.00% |